The relationship and threshold of stent length with regard to risk of stent thrombosis after drug-eluting stent implantation

JACC: Cardiovascular Interventions

Volumn 3, Issue 4, 2010, Pages 383-389

  Suh, Jon ^a   Park, Dgbr Woo ^b   Lee, Jong Young ^b   Jung, In Hyun ^b   Lee, Seung Whan ^b   Kim, Young Hak ^b   Lee, Cheol Whan ^b   Cheong, Sang Sig ^b   Kim, Jae Joong ^b   Park, Seong Wook ^b   Park, Seung Jung ^b  

^a Soonchunhyang University College of Medicine   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

Author keywords

drug eluting stent; stent length; stentthrombosis

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; HEPARIN; PACLITAXEL; RAPAMYCIN; ANTITHROMBOCYTIC AGENT;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG ELUTING STENT; DRUG WITHDRAWAL; FEMALE; HEART DEATH; HEART INFARCTION; HUMAN; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RESTENOSIS; RISK; SENSITIVITY AND SPECIFICITY; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STENT THROMBOSIS; CHI SQUARE DISTRIBUTION; CLINICAL TRIAL; INCIDENCE; INSTRUMENTATION; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; PROPORTIONAL HAZARDS MODEL; PROSTHESIS; RISK ASSESSMENT; RISK FACTOR; SOUTH KOREA; THROMBOSIS; TIME; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CHI-SQUARE DISTRIBUTION; DRUG-ELUTING STENTS; FEMALE; HUMANS; INCIDENCE; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PLATELET AGGREGATION INHIBITORS; PROPORTIONAL HAZARDS MODELS; PROSTHESIS DESIGN; REPUBLIC OF KOREA; RISK ASSESSMENT; RISK FACTORS; THROMBOSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 77954680991     PISSN: 19368798     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcin.2009.10.033     Document Type: Article

References (22)

1. M.C. Morice, P.W. Serruys, and J.E. Sousa A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization N Engl J Med 346 2002 1773 1780
2. J.W. Moses, M.B. Leon, and J.J. Popma Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery N Engl J Med 349 2003 1315 1323
3. G.W. Stone, S.G. Ellis, and D.A. Cox A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease N Engl J Med 350 2004 221 231
4. I. Iakovou, T. Schmidt, and E. Bonizzoni Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents JAMA 293 2005 2126 2130
5. P. Urban, A.H. Gershlick, and G. Guagliumi Safety of coronary sirolimus-eluting stents in daily clinical practice: one-year follow-up of the e-Cypher registry Circulation 113 2006 1434 1441
6. P.K. Kuchulakanti, W.W. Chu, and R. Torguson Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus- and paclitaxel-eluting stents Circulation 113 2006 1108 1113
7. G.G.L. Biondi-Zoccai, P. Agostoni, and G.M. Sangiorgi Incidence, predictors, and outcomes of coronary dissections left untreated after drug-eluting stent implantation Eur Heart J 27 2006 540 546
8. K. Fujii, S.G. Carlier, and G.S. Mintz Stent underexpansion and residual reference segment stenosis are related to stent thrombosis after sirolimus-eluting stent implantation: an intravascular ultrasound study J Am Coll Cardiol 45 2005 995 998
9. J.A. Spertus, R. Kettelkamp, and C. Vance Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: results from the PREMIER registry Circulation 113 2006 2803 2809
10. D.W. Park, S.W. Park, and K.H. Park Frequency of and risk factors for stent thrombosis after drug-eluting stent implantation during long-term follow-up Am J Cardiol 98 2006 352 356
11. R. Moreno Drug-eluting stent thrombosis J Am Coll Cardiol 45 2005 954 959
12. E.P. McFadden, E. Stabile, and E. Regar Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy Lancet 364 2004 1519 1521 (Pubitemid 39410418)
13. W.K. Laskey, C.W. Yancy, and W.H. Maisel Thrombosis in coronary drug-eluting stents: report from the meeting of the Circulatory System Medical Devices Advisory Panel of the Food and Drug Administration Center for Devices and Radiologic Health, December 78, 2006 Circulation 115 2007 2352 2357
14. D.E. Cutlip, S. Windecker, and R. Mehran Clinical end points in coronary stent trials: a case for standardized definitions Circulation 115 2007 2344 2351
15. K. Thygesen, J.S. Alpert, H.D. White Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction Universal definition of myocardial infarction J Am Coll Cardiol 50 2007 2173 2195 (Pubitemid 350123680)
16. D.E. Cutlip, D.S. Baim, and K.K.L. Ho Stent thrombosis in the modern era: a pooled analysis of multicenter coronary stent clinical trials Circulation 103 2001 1967 1971
17. P.W. Serruys, J. Daemen, and M.C. Morice Three-year follow-up of the ARTS-IIsirolimus-eluting stents for the treatment of patients with multivessel coronary artery disease Euro Intervention 3 2008 450 459
18. A. Chieffo, E. Bonizzoni, and D. Orlic Intraprocedural stent thrombosis during implantation of sirolimus-eluting stents Circulation 109 2004 2732 2736 (Pubitemid 38737920)
19. P.W. Serruys, A.T. Ong, and M.C. Morice Arterial Revascularization Therapies Study Part IIsirolimus-eluting stents for the treatment of patients with multivessel de novo coronary artery lesions EuroIntervention 1 2005 147 156
20. M. Degertekin, C.A. Arampatzis, and P.A. Lemos Very long sirolimus-eluting stent implantation for de novo coronary lesions Am J Cardiol 93 2004 826 829
21. Y.H. Kim, S.W. Park, and C.W. Lee Comparison of sirolimus-eluting stent, paclitaxel-eluting stent, and bare metal stent in the treatment of long coronary lesions Catheter Cardiovasc Interv 67 2006 181 187
22. P.W. Serruys, D.P. Foley, and M.J. Suttorp A randomized comparison of the value of additional stenting after optimal balloon angioplasty for long coronary lesions: final results of the additional value of NIR stents for treatment of long coronary lesions (ADVANCE) study J Am Coll Cardiol 39 2002 393 399